Most people who have HIV get a rash at some point. It’s a common symptom that can happen in early (acute) or later stages of an HIV infection. Because your body’s immune system is trying to ...

Is there an HIV epidemic? There are several factors making the issue of HIV and AIDs among Black folks very concerning.

HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...

The company has announced results from the first group of patients in its most recent phase 2a trial testing the potential HIV cure treatment codenamed ABX464. The study aimed at accessing the ...

HOOKIPA Pharma Inc. has announced the completion of participant enrollment in a Phase 1b clinical trial for HB-500, a next-generation therapeutic vaccine aimed at treating HIV. The trial ...

Therefore, CXCR4 inhibitors have potential as novel therapeutics for the treatment of these diseases as well as HIV infection. ALX40-4C NPS Allelix Terminated (Phase I/II) HIV No apparent effect ...

HOOKIPA Pharma (HOOK) announced that enrollment is complete in the Phase 1b clinical trial evaluating HB-500 for the treatment of HIV, with 30 ...

The Phase 1b clinical trial (NCT06430905) is evaluating the safety and tolerability, reactogenicity, and immunogenicity to repeated doses of HB-500 in participants with HIV on suppressive ...